cPass™ Technology by GenScript
Coronaviruses are a large family of viruses that may cause illness in animals or humans. In humans, several coronaviruses are known to cause respiratory infections ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The most recently discovered coronavirus causes coronavirus disease COVID-19.
Is there a vaccine, drug or treatment for COVID-19?
While some western, traditional or home remedies may provide comfort and alleviate symptoms of mild COVID-19, there are no medicines that have been shown to prevent or cure the disease. Who does not recommend self-medication with any medicines, including antibiotics, as a prevention or cure for COVID-19.
However, there are several ongoing clinical trials of both western and traditional medicines. Who is coordinating efforts to develop vaccines and medicines to prevent and treat COVID-19 and will continue to provide updated information as soon as research results become available.
COVID-19 Testing Overview
COVID-19 had an enormous impact worldwide. A reliable testing strategy is needed so life can return to normal.
Two kinds of tests are available for COVID-19: viral tests and antibody tests.
- A viral test tells you if you have a current infection.
- An antibody test might tell you if you had a past infection.
Detecting the presence of viral RNA in body fluid gives a snapshot of a person’s current infection status. It doesn’t reveal information about past infection or future immunity because the RNA disappears when the patient recovers.
However, antibodies remain in the blood even after the recovery, so testing the antibodies can detect previous infections. However, only a subset of antibodies is capable of blocking future viral infection. These are called Neutralizing antibodies.
cPass™ SARS-CoV-2 Neutralization Antibody Test
cPass Neutralization Antibody Detection kit detects circulating neutralizing antibodies against SARS-CoV-2 that block the interaction between the receptor binding domain (RBD) of the viral spike glycoprotein with the ACE2 cell surface receptor.
This kit would be instrumental in vaccine and therapeutic development as it is suitable for all antibody isotypes and can be used to determine neutralizing antibodies in animal models without modification. The kit will also help in current COVID-19 investigations of seroprevalence, assessment of herd immunity, the longevity of protective immunity, the efficacy of different vaccine candidates as well as tracking infection in animals.
3DforScience is a scientific communication company specialized in digital content for the pharma and biotech industries. Our passionate creative team works alongside an in-house scientific team to provide cutting-edge medical animations, scientific illustrations, virtual reality, etc.
Our extensive experience within the field ensures all the content we produce is scientifically accurate, innovative, engaging, and pitched at the right level for the target audience. Wold you like to bring your scientific messaging to life? Contact us. We would love to help you create something unique.